期刊文献+

星形细胞瘤中P53、VEGF及PCNA表达的相关性及其与预后的关系 被引量:3

Expressions of P53, vascular endothelial growth factor and proliferating cell number antigen in astrocytomas and prognosis of these patients
原文传递
导出
摘要 目的研究星形细胞瘤中P53、血管内皮因子(vEGF)及增殖细胞核抗原(PCNA)表达的相关性及其与预后的关系。方法免疫组化染色sP法检测梅州市人民医院自2002年5月至2010年5月首次手术切除的126例不同级别原发性星形细胞瘤标本P53、VEGF及PCNA的表达,分析其相关性及其预后意义。结果P53、VEGF及PCNA在不同级别的星形细胞瘤中表达不同,随着级别的提高而表达强度增加,差异有统计学意义(P〈0.05);P53与PCNA、P53与VEGF之间表达呈正相关关系(r=0.608,P=0.000;r=0.432,P=0.001)。相同级别星形细胞瘤中,P53阳性表达患者预后较差,生存率比较差异有统计学意义(P〈0.05),VEGF及PCNA与预后无关。结论星形细胞瘤级别提高,P53、VEGF及PCNA的表达强度增加:P53可作为判断肿瘤预后的指标之一。 Objective To study the expressions of P53, vascular endothelial growth factor (VEGF) and proliferating cell nuclear antigen (PCNA) in astrocytomas and their relationships with prognosis of these patients. Methods Immunohistochemical SP method was employed to detect the P53, VEGF and PCNA expression in 126 cases of human brain astrocytomas of different grades, collected in our hospital from May 2002 to May 2010; their correlations and their significance in the prognosis in these patients were analyzed. Results P53, VEGF, and PCNA expressed differently in astrocytomas of different grades, enjoying a positive relation with grades (P〈0.05); positive correlations of between P53 expression and both VEGF and PCNA expressions (r=0.608, P=-0.000; r=0.432, P=0.001). In patients with the same grade of astrocytoma, those having positive P53 expression enjoyed poorer prognosis and lower survival rate with significant difference (P〈0.05); while VEGF and PCNA expressions had no correlation with the progonosis. Conclusion The expressions of PCNA, VEGF and P53 are closely associated with grade of the astrocytomas, and only P53 expression is an indicator of poor prognosis.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2014年第4期340-342,共3页 Chinese Journal of Neuromedicine
基金 梅州市医药卫生科研课题(2011-B-7)
关键词 星形细胞瘤 P53 血管内皮因子 增殖细胞核抗原 Astrocytoma P53 Vascular endothelial growth factor Proliferating cell nuclear antigen
  • 相关文献

参考文献8

二级参考文献24

  • 1丁涟沭,刘道坤,邓传宗,顾志垲,陈建,高宜录,沈剑虹.幕上星形细胞肿瘤Ki-67抗原表达及其预后作用[J].中华神经医学杂志,2004,3(5):334-336. 被引量:5
  • 2徐燕杰,王政民,张玉芝.增殖细胞核抗原在星形细胞瘤中的表达[J].中华神经外科杂志,1994,10(4):216-217. 被引量:18
  • 3董伦,浦佩玉,王虎,康春生,王广秀.胶质瘤中EGFR扩增、过表达及其与肿瘤增殖关系的研究[J].中华神经医学杂志,2005,4(12):1204-1207. 被引量:8
  • 4Scholzen T,Gerdes J.The Ki-67 protein:from the known and the unknown[J].J Cell Physiol,2000,182(3):311-322.
  • 5Zhang W,DeMattia JA,Song H,et al.Communication between malignant glioma cells and vascular endothelial cells through gap junctions[J].J Nettrosurg,2003,98(4):846-853.
  • 6Schroder R,Feisel KD,Emestus RI.Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas[J].J Neurooncol,2002,56(2):127-132.
  • 7Kayaselcuk F,Zorludemir S,Gumurduhu D,et al.PCNA and Ki-67 in central nervous system tumors:correclation with the histological and grade[J].J Neurooncol,2002,57(2):115-121.
  • 8Beldi A, Pasricha P J, Akhtar, et al. Inhibition of apoptosis during development of colorectal cancer [J]. Cancer Res, 1995,55:1811 - 1816.
  • 9Kleihues P, Ohgaki H. Phenotype vs genotype in the evolution of as- trocytic brain tumors [J]. Toxicol Pathol, 2000,28( 1 ): 164 - 170.
  • 10Natalie DM, Alexander Z, Ute MM, et al. Death signal-induced local- ization of p53 protein to mitochondria. A potenial role in apoptotic signaling [J]. J Biol Chem ,2000,275: 16202-16212.

共引文献12

同被引文献29

  • 1张云静,戴德.乙酰肝素酶靶向治疗对肿瘤生长的影响[J].广东医学院学报,2014,32(1):93-95. 被引量:1
  • 2刘子沛,王曙光,崔彦.真核细胞翻译起始因子4E在肿瘤发生与发展中的作用[J].消化外科,2006,5(4):295-298. 被引量:1
  • 3Wrenseh M,Minn Y,Chew T,et al.Epidemiology of primary brain tumor:current concepts and review of the literature.Neum Oncol,2002,4:278-299.
  • 4Bilgic CI,Tez M.Serum VEGF levels in gastric cancer patients:correlation with clinicopathological parameters.Turkish Journal of Medical Sciences,2015,45:112-117.
  • 5Mamane Y,Petroulakis E,Rong L,et al.eI F4E-from translation to transformation.Oncogene,2004,23:3172-3179.
  • 6Culjkovic B,Borden KL.Understanding and targeting the eukaryotic translation initiation factor eI F4E in head and neck cancer.J Oncol,2009,98:1679.
  • 7Assouline S,Culjkovic B,Cocolakis E,et al.Molecular targeting of the oncogene eI F4E in acute myeloid leukemia(AML):a proof-ofprinciple clinical trial with ribavirin.Blood,2009,114:257-260.
  • 8Borden KL,Culjkovic-Kraljacic B.Ribavirin as an anti-cancer therapy:acute myeloid leukemia and beyond.Leuk Lymphoma,2010,51:1805-1815.
  • 9Kerekatte V,Smiley K,Hu B,et al.The proto-oncogene/translation factor eI F4E:a survey of its expression in breast carcinomas.Int J Cancer,1995,64:27-31.
  • 10张波,朱成楚,陈保富,章霞,叶敏华,林爱芬.eIF4E基因在非小细胞肺癌中的表达及意义[J].中国肺癌杂志,2010,13(12):1132-1135. 被引量:8

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部